Japanese Circulation Society

Short and Long Term Effect of the Combination Therapy of Epoprostenol and Bosentan for Patients with Pulmonary Arterial Hypertension

Figure 2. Cardiac output reduction achieved with epoprostenol short-term maintained at 1 year.